These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20600619)

  • 1. LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor.
    Hedlund PB; Leopoldo M; Caccia S; Sarkisyan G; Fracasso C; Martelli G; Lacivita E; Berardi F; Perrone R
    Neurosci Lett; 2010 Aug; 481(1):12-6. PubMed ID: 20600619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT(1B) receptor knockout mice show no adaptive changes in 5-HT(1A) receptor function as measured telemetrically on body temperature and heart rate responses.
    Bouwknecht JA; Hijzen TH; van der Gugten J; Maes RA; Hen R; Olivier B
    Brain Res Bull; 2002 Jan; 57(1):93-102. PubMed ID: 11827741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study.
    Lacivita E; Podlewska S; Speranza L; Niso M; Satała G; Perrone R; Perrone-Capano C; Bojarski AJ; Leopoldo M
    Eur J Med Chem; 2016 Sep; 120():363-79. PubMed ID: 27318552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols.
    Peglion JL; Goument B; Despaux N; Charlot V; Giraud H; Nisole C; Newman-Tancredi A; Dekeyne A; Bertrand M; Genissel P; Millan MJ
    J Med Chem; 2002 Jan; 45(1):165-76. PubMed ID: 11754589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523.
    Tottori K; Miwa T; Uwahodo Y; Yamada S; Nakai M; Oshiro Y; Kikuchi T; Altar CA
    Neuropharmacology; 2001 Dec; 41(8):976-88. PubMed ID: 11747902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.
    Newman-Tancredi A; Rivet J; Chaput C; Touzard M; Verrièle L; Millan MJ
    Eur J Pharmacol; 1999 Nov; 384(2-3):111-21. PubMed ID: 10611431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between 5-HT(1A) and 5-HT(1B) receptors: effects of 8-OH-DPAT-induced hypothermia in 5-HT(1B) receptor knockout mice.
    Gardier AM; Gruwez B; Trillat AC; Jacquot C; Hen R; Bourin M
    Eur J Pharmacol; 2001 Jun; 421(3):171-5. PubMed ID: 11516433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.
    Hedlund PB; Kelly L; Mazur C; Lovenberg T; Sutcliffe JG; Bonaventure P
    Eur J Pharmacol; 2004 Mar; 487(1-3):125-32. PubMed ID: 15033384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of S-(-)-2-[[4-(napht-1-yl)piperazin-1-yl]methyl]-1,4-dioxoperhydropyrrolo[1,2-a]pyrazine (CSP-2503) using computational simulation. A 5-HT1A receptor agonist.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Olivella M; Pardo L; Delgado M; Manzanares J; Fuentes JA
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1429-32. PubMed ID: 12668005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III.
    Leopoldo M; Lacivita E; De Giorgio P; Fracasso C; Guzzetti S; Caccia S; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2008 Sep; 51(18):5813-22. PubMed ID: 18800769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of 1,2,4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors.
    Chilmonczyk Z; Cybulski M; Iskra-Jopa J; Chojnacka-Wójcik E; Tatarczyńska E; Kłodzińska A; Leś A; Bronowska A; Sylte I
    Farmaco; 2002 Apr; 57(4):285-301. PubMed ID: 11989808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
    Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A; Verrièle L; Millan MJ
    Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.
    Jordan S; Koprivica V; Chen R; Tottori K; Kikuchi T; Altar CA
    Eur J Pharmacol; 2002 Apr; 441(3):137-40. PubMed ID: 12063084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
    Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
    J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging.
    Lemoine L; Verdurand M; Vacher B; Blanc E; Le Bars D; Newman-Tancredi A; Zimmer L
    Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):594-605. PubMed ID: 19789870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.